Breast Response Prediction

HER2-positive metastatic breast cancer

Treatment Context

HER2-targeted antibody therapy

Endpoints: PFS and OS — Multimodal benefit prediction powered by Salt

Cohort Filters

Line of Therapy

Prior HER2 Exposure

HER2 Intensity

Biomarker Signature

This analysis will assemble a cohort from Oracle Health clinical records and EMI multimodal data, run survival prediction models on OCI compute, interpret biological drivers of treatment benefit separation, and generate ranked preclinical mechanism experiment suggestions. The full Salt pipeline executes locally on your OCI instance.

Oracle Health — Clinical Records

EMI — Biomarker & Molecular Data

OCI — Local Compute (us-ashburn-1)

Salt — Analysis Engine v2.4.1